Should We Be Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Treating Diabetes?
作者信息
Packer Milton
机构信息
Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Tex.
出版信息
Am J Med. 2018 May;131(5):461-463. doi: 10.1016/j.amjmed.2017.11.052. Epub 2018 Jan 5.
PMID:29309741
Abstract
摘要
Zotero 插件